After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Earlier, Yahoo Finance discussed this stock as it revealed Orchestra BioMed Demonstrates Strength of Cardiovascular Pipeline with Virtue® SAB and AVIM Therapy Presentations at CRT 2024 Annual Meeting.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
This NYSE-listed company operates within the Medical Devices industry segment, falling under the Healthcare sector. The current market capitalization of Medtronic Plc is $112.05B. A total of 7.22 million shares were traded on the day, compared to an average of 6.15M shares.
In the most recent transaction, Salmon Sean sold 30,695 shares of MDT for 85.13 per share on Feb 21 ’24. After the transaction, the EVP & President Cardiovascular now owns 48,289 company shares. In a previous transaction on Dec 19 ’23, Wall Brett A. sold 4,997 shares at 82.17 per share. MDT shares that EVP & Pres Neuroscience owns now total 28,910.
Among the insiders who sold shares, Smith Gregory L disposed of 10,000 shares on Aug 23 ’23 at a per-share price of $83.84. This resulted in the EVP Global Ops & Supply Chain holding 46,723 shares of MDT after the transaction. In another insider transaction, Wall Brett A. sold 1,000 shares at $83.38 per share on Aug 14 ’23. Company shares held by the EVP & Pres Neuroscience now total 33,573.
Dividend
The income generated by dividends is an indication that a company is improving its financial position, which is why investors prefer companies paying dividends. Medtronic Plc pays an annual dividend of $2.75, resulting in a dividend yield of 3.26%, and it has a price to earnings (P/E) ratio of 26.77. MDT’s most recent ex-dividend date was 3/21/2024 when it declared a $0.69 quarterly dividend that was paid in cash on 4/12/2024. Previously, the company paid the dividend on 1/12/2024 with an ex-dividend date of 12/19/2023. The MDT stock dividend was $0.69 per share in cash.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, MDT has a high of $92.02 and a low of $68.84.
As of this writing, MDT has an earnings estimate of $1.45 per share for the current quarter. EPS was calculated based on a consensus of 27 estimates, with a high estimate of $1.46 per share and a lower estimate of $1.44. The company reported an EPS of $1.25 in the last quarter, which was 5.90% higher than expectations of $1.18.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. MDT’s latest balance sheet shows that the firm has $10.57B in Cash & Short Term Investments as of fiscal 2022. There were $24.11B in debt and $12.39B in liabilities at the time. Its Book Value Per Share was $38.95, while its Total Shareholder’s Equity was $52.72B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MDT is Buy with a score of 3.76.
